Anhydrovinblastine: IGT filed a Canadian IND to begin Phase I testing

IGT Pharma Inc. (VSE:IGT), Vancouver, B.C. Product: Anhydrovinblastine (AVLB) Indication: Treat lung cancer Status: IGT filed a Canadian IND to begin Phase I testing. ...